Benzel

Quick links to important sections

Benzel

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Benzel

Property Description
Active ingredient Chlorphenamine maleate
Form Tablets, Capsules, Liquid Oral Suspension
Pharmacological class First-Generation Antihistamine
Common use Symptomatic relief of allergic conditions
Origin Synthetic Alkylamine Derivative

Benzel is the designation for a medication containing the active ingredient Chlorphenamine maleate, which is pharmacologically classified as a synthetic first-generation antihistamine belonging to the alkylamine derivative group. Chlorphenamine is a single, active chemical entity, positioning the final product as a single-ingredient monotherapy. Chlorphenamine is a clinically recognized agent employed to help relieve symptoms stemming from allergic reactions.

The compound's structure is the maleate salt of a racemic mixture. This formulation is characterized by its efficacy within its class, which is a key characteristic differentiating it from later, more selective antihistamine generations.

Classification and General Purpose of Chlorphenamine

This medication belongs to the antihistamine pharmacological class and operates as an H₁-receptor antagonist, blocking the effects of histamine released during allergic responses. Chlorphenamine is recognized as an essential medicine due to its established utility and reliability in mitigating widespread allergic phenomena.

The general therapeutic purpose of this antagonism is the high-level management of physiological reactions caused by histamine, providing relief for discomfort often associated with hay fever or other common allergic conditions.

Available Forms and Composition

Chlorphenamine maleate is formulated for oral administration and is available in several distinct pharmaceutical preparations, including standard tablets, capsules, and a liquid oral suspension. The high-level composition consists of the active substance, Chlorphenamine maleate, combined with inert excipients in solid forms, or an aqueous vehicle for the liquid medicine. These specific preparations ensure the therapeutic compound can be efficiently delivered for systemic effect.

What side effects are possible with Benzel?

Possible Side Effects and Safety Information

The official documentation regarding Chlorphenamine maleate, a first-generation antihistamine, classifies its adverse effects based on the physiological systems involved and their estimated frequency as reported in clinical use and post-marketing surveillance. This presentation of safety information is strictly aligned with regulatory documents like the Summary of Product Characteristics (SmPC).

Adverse Reactions by Frequency and System Organ Class

The most frequently documented adverse effects primarily involve the Nervous System and are classified as Very Common (ge10% incidence). These include sedation and somnolence (drowsiness).

Adverse reactions classified as Common (ge1% to <10% incidence) affect several organ systems, including: Nervous System Disorders (disturbance in attention, dizziness, headache), Gastrointestinal Disorders (nausea, dry mouth), Eye Disorders (blurred vision), and General Disorders (fatigue).

Less frequent effects are classified as Frequency Unknown, often identified during post-marketing surveillance. These include serious systemic and haematological reactions such as anaphylactic reactions, blood dyscrasias, hepatitis, and jaundice, along with potential cardiac arrhythmias and hypotension.

Safety Considerations for Specific Populations

Regulatory documents note that both children and older adults are more susceptible to experiencing certain adverse effects, including neurological anticholinergic effects and paradoxical excitation (e.g., restlessness). Caution is also advised in patients with hepatic impairment and renal impairment.

Safety-Related Restrictions

The drug's anticholinergic properties necessitate caution in individuals with pre-existing conditions like epilepsy, glaucoma, or prostatic hypertrophy. Concurrent use with alcohol or other Central Nervous System (CNS) depressants may result in an additive increase in sedative effects, which is explicitly noted as a safety concern in the official labeling.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Benzel (Chlorphenamine maleate) overdose defines specific, serious manifestations and mandates immediate emergency action. The estimated lethal dose of the substance is documented to be in the range of 25 to 50 mg/kg body weight.

Feature Official Regulatory Statements
Documented Manifestations Overdose may present with Central Nervous System effects, including sedation, toxic psychosis, convulsions (seizures), and paradoxical excitation. Anticholinergic effects such as mydriasis and urinary retention are also documented.
Life-Threatening Outcomes Severe consequences include cardiovascular collapse, severe arrhythmias, and respiratory failure.
Population-Specific Note Children and the elderly are explicitly noted as more likely to experience both neurological anticholinergic effects and paradoxical excitation.
Emergency Action Individuals must seek emergency medical attention immediately. Emergency services should be contacted if symptoms involve collapse, a seizure, trouble breathing, or inability to be awakened.

Supportive Care and Regulatory Basis

Management must rely solely on symptomatic and supportive measures as the regulatory basis confirms no specific antidote is available. Procedures described for oral ingestion may include activated charcoal administration and gastric lavage. Monitoring requires special attention to cardiac, respiratory, renal, and hepatic functions to manage the systemic effects.

Therapeutic Uses of Benzel

Benzel (Chlorphenamine maleate) is generally applied in contexts where additional symptomatic support is needed for conditions involving allergic and irritative states. The medication is commonly used to address symptoms related to allergic rhinitis, hay fever, and the common cold. Its therapeutic benefit is centered on easing the overall symptom burden, which may contribute to improved comfort and support functional stability during symptomatic periods.

Relief from Allergic and Cold-Related Nasal Symptoms

This domain may assist with addressing symptom clusters such as sudden, repeated sneezing and excessive, watery runny nose (rhinorrhea). Providing support in these areas contributes to easing the overall symptom load and may assist with maintaining functional stability during symptomatic phases. It is also commonly used to help with the intense localized itching that follows insect bites and stings and the temporary, raised lesions of urticaria (hives).


Quick Fact: Symptomatic Support for Dermal Discomfort

Benzel is commonly used in addressing bothersome dermal manifestations like generalized pruritus and urticaria, providing support that helps patients cope more steadily with symptom fluctuations.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Official Eligibility and Contraindications

The eligibility for using Benzel (Chlorphenamine maleate) is strictly defined by regulatory bodies based on age, concurrent medication use, and specific underlying health conditions.

Eligibility Status Affected Populations
Absolute Contraindication Newborn and premature infants must not use this medicine. Use is also strictly prohibited for patients with known hypersensitivity to the drug or those who have received MAOIs within the last 14 days.
Condition Restriction Contraindications include primary angle-closure glaucoma, conditions leading to urinary retention (e.g., prostatic hypertrophy), and during an acute asthma attack.

Age and Special Populations

The medicine is generally used by adults and children 12 years and over. Use is not recommended for children under 6 years. Caution is mandatory for the elderly due to their increased susceptibility to certain effects, and use should be avoided in elderly patients with confusion.

Conditional Use

Patients with hepatic impairment, renal impairment, epilepsy, or severe cardiovascular disease are subject to the use with caution classification. During pregnancy and lactation, use is generally not recommended and is restricted to cases deemed essential by a physician.

What should I know about interactions with other medicines?

The official regulatory profile for Benzel (Chlorphenamine maleate) establishes several documented interaction patterns, primarily categorized by additive pharmacodynamic effects and altered substance clearance. These statements originate from government-issued Prescribing Information and Summaries of Product Characteristics.

Formal Restrictions and Contraindications

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is formally contraindicated in regulatory labeling. This restriction applies to concurrent use and requires a mandatory 14-day period following the cessation of MAOI therapy before Benzel can be administered. Concomitant use with Alcohol is noted to potentiate sedative effects and should be avoided. Official labeling also restricts co-administration with other Antihistamine-Containing Products.

Pharmacodynamic and Exposure Modification

The drug’s interaction profile identifies substances that reinforce its effects. Concurrent use with CNS Depressants (such as opioid analgesics, hypnotics, and antipsychotics) may lead to an increase in sedative effects. Similarly, combining with Anticholinergic Agents can potentiate the drug’s antimuscarinic properties. Regarding clearance, the drug is documented to inhibit the metabolism of Phenytoin, leading to its reduced clearance and the risk of Phenytoin toxicity.

Population-Specific Note

A specific caution is noted for patients with hepatic impairment, as they may face an increased risk of adverse effects due to the potential for drug and metabolite accumulation stemming from clearance modification.

Mechanism of Action

Benzel, whose active ingredient is rufinamide, primarily modulates the activity of voltage-gated sodium channels, a key biological target within neuronal tissue. The molecule acts as a sodium channel modulator, specifically by prolonging the channel's inactive state. This mechanism limits the channel's ability to transition rapidly back to an open, activated state following a depolarization event.

Intracellularly, this prolongation decreases the availability of the sodium channels for high-frequency, sustained repetitive firing of action potentials in hyperexcitable neurons. By stabilizing the inactive state, the drug functionally reduces the influx of sodium ions and dampens neuronal excitability.

At a system level, the resulting modulation of neural membrane stability contributes to a reduction in the spread of excessive neuronal discharge throughout the central nervous system.

Dosage and Administration Information

How Benzel is Used

Benzel (Chlorphenamine maleate) is used for oral administration in the form of immediate-release tablets, capsules, and a liquid suspension. The specific usage patterns—including dosing, frequency, and duration—are standardized across these oral formulations.


Standard Dosing and Frequency

Administration of the immediate-release 4 mg tablet or equivalent liquid dose is typically on an as-needed basis. For adults and adolescents 12 years and older, the standard dose is 4 mg taken every 4 to 6 hours. It is required to maintain a minimum interval of 4 hours between doses. The total daily intake is strictly limited, with the maximum dose for adults not to exceed 24 mg in any 24-hour period.


Administration Context and Specific Rules

Benzel may be taken with or without food. For the liquid suspension, doses must be measured using an accurate measuring device provided with the medication, and not by a household spoon, to ensure dose precision. If an extended-release formulation is administered, it must be swallowed whole and not crushed or chewed, as this compromises the sustained release mechanism.

Use of Benzel is generally intended for short-term relief of acute symptoms. Continuous use of the medicine should not exceed two weeks without guidance from a health professional.


Population-Specific Use

Specific dose reductions exist for certain groups. For children aged 6 to 12 years, the dose is 2 mg every 4 to 6 hours, with a daily maximum of 12 mg. Furthermore, in older adults, a lower maximum daily dose, often limited to 12 mg, is used in many regions due to heightened sensitivity to the medication.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Benzel (Chlorphenamine maleate)

This section provides an overview of the research evidence and study patterns for Chlorphenamine maleate, a first-generation antihistamine, focusing on how its use was studied for various physiological responses according to official and peer-reviewed sources.

Evidence for Use in Allergic Rhinitis (Hay Fever)

Research regarding this use is available, but it is important to note the nature of the data. This evidence primarily consists of short-term randomized controlled trials (RCTs). The study populations typically included adults and adolescents. Researchers primarily monitored patient-reported outcomes describing perceived discomfort, measuring scores that quantify symptoms like sneezing, runny nose (rhinorrhea), and nasal itching.

Findings describe patterns observed in the studies, which included reported measurements related to these specific symptom endpoints over brief assessment periods. The research focus centers on symptomatic changes rather than long-term management of underlying conditions.

Evidence for Temporary Symptom Relief in the Common Cold

Chlorphenamine maleate was studied for temporary symptom relief, often as one agent within a fixed-dose combination alongside other symptom-relieving medicines. Systematic reviews and trials examined specific symptoms and reported changes measured during the study period related to specific symptoms like sneezing and runny nose. Evidence for the single ingredient monotherapy research in the common cold setting is limited.

Key Research Gaps and Unanswered Questions

The quality of the evidence base varies significantly; many supporting studies for this first-generation drug are older trials and may not fully adhere to current methodological standards for reporting bias and randomization. Limited information for long-term outcomes exists, particularly concerning the maintenance of symptomatic changes. Data for certain groups, including older adults, remain insufficient, and the results apply only to the populations studied in the existing research.

Key Studies & References

  1. Appropriate use of second-generation antihistamines - Cleveland Clinic Journal of Medicine

Frequently Asked Questions (FAQ)

Common questions about Benzel (FAQ)


Q: Is Benzel considered a maintenance medication or only for short-term use?

Official regulatory documents indicate that this medication is approved for the temporary relief of symptoms related to allergies. It is generally intended for short-term use, and continuous administration should not extend beyond a defined period without consulting a health professional.


Q: Why do people say Benzel makes them feel tired?

Regulatory documents list sedation and somnolence, which means drowsiness or feeling tired, as Very Common adverse effects. This effect is expected because Benzel is a first-generation antihistamine that acts on the central nervous system.


Q: How quickly should someone expect to notice the effects of Benzel?

Based on professional prescribing information, the effects of the conventional formulation are typically apparent within 6 hours after taking a single oral dose. This onset pattern is related to the drug's absorption and activity in the body.


Q: Can Benzel cause sensitivity to the sun?

Regulatory-aligned patient information states that this medication can potentially make a person more sensitive to the sun, a condition known as photosensitivity. Official information notes that avoiding sun exposure, sun lamps, and tanning beds is generally advised due to this potential.


Q: Is Benzel available generically?

Benzel is a designation for the active ingredient, which is Chlorphenamine maleate. This compound is commonly available under its generic name, as well as in various other brand names and combination medicines.


Q: How long does Benzel stay in the system?

Pharmacokinetic data available in professional prescribing information shows that the time it takes for half of the drug to be eliminated, known as the half-life, is estimated to be approximately 12 to 43 hours in adults. The duration of symptomatic relief is generally shorter than the elimination half-life.


Q: Are there any dietary restrictions mentioned while taking Benzel?

The official labeling provides a formal warning that alcoholic beverages should be avoided due to the potential for increased drowsiness and other central nervous system effects. The documentation does not generally list specific warnings or restrictions for solid food products.


Q: Can men and women use Benzel for the same duration?

The official prescribing instructions and dosing information for adults and adolescents do not differentiate between male and female patients regarding the maximum recommended dose or the typical treatment duration.


Q: Are there any long-term side effects associated with Benzel use?

The official safety documentation lists adverse effects based on acute use and post-marketing surveillance. The research overview notes that there is limited information available for long-term outcomes that extend significantly beyond the typical short duration of use.


Q: Do different brands of Benzel have the same effectiveness?

For generic versions of Chlorphenamine maleate to receive regulatory approval, they must generally meet standards that demonstrate bioequivalence to the original product. Bioequivalence means that the generic formulation delivers the active drug into the bloodstream at the same rate and extent as the reference product.


Q: Does Benzel affect blood pressure or blood sugar?

Official safety data lists hypotension (low blood pressure) as a potential adverse effect, and the drug is used with caution in patients with cardiovascular disease. Standard product monographs for the single-ingredient formulation generally do not list warnings specific to blood sugar metabolism.


Q: Is Benzel the same as 'Drug X'?

Benzel is a name used for the active ingredient Chlorphenamine maleate, which is a first-generation antihistamine. Determining if it is the 'same' as another product relies on verifying whether that product also contains Chlorphenamine maleate as its active ingredient.


Q: Does Benzel interact with herbal supplements like St. John's Wort?

The official interactions list is limited to formal drug-drug restrictions, such as MAOIs and CNS depressants. The documentation generally does not provide tested safety information or warnings for specific herbal products or supplements.


Q: Can Benzel be taken alongside vitamins or mineral supplements?

Official regulatory documents provide a list of formal restrictions for prescription and over-the-counter medicines. However, they do not typically list specific vitamins or mineral supplements as known interacting substances.


Q: Is Benzel effective for all stages of the condition it treats?

The drug's official purpose and the existing research evidence confirm its use for the symptomatic relief of acute allergic conditions. The evidence is primarily focused on short-term changes and does not support claims of effectiveness across all stages or long-term disease modification.


Q: How do regulators describe the risk profile of Benzel?

Regulatory bodies document the risk profile through a detailed list of Warnings, Cautions, and Adverse Reactions. This profile highlights the very common CNS effects like sedation and lists less frequent but potentially more serious systemic reactions, such as blood disorders or severe allergic responses.


Q: What should be done if a severe allergic reaction to Benzel is suspected?

Official patient guidance states that a severe allergic reaction (such as swelling of the face, tongue, or throat) is an event for which immediate medical attention is sought. The guidance also describes contacting emergency services or a poison control center as the necessary action in the event of a suspected overdose.


Q: What happens if a dose of Benzel is forgotten?

Official patient information commonly describes that if a dose is forgotten, it is to be taken as soon as it is remembered. However, if it is close to the time for the next scheduled dose, the guidance describes skipping the missed dose to avoid taking an extra dose.


Q: Is the severity of side effects from Benzel dose-dependent?

Regulatory documents suggest a relationship between dose and effect by advising lower maximum daily doses for older adults due to their increased susceptibility to adverse effects. This indication suggests that the risk of adverse effects is considered by regulators to be related to the administered dose.


Q: What are the criteria for stopping Benzel treatment?

Benzel is designed for the temporary relief of symptoms. The primary criterion for stopping the medication is generally the resolution of the acute symptoms it is being used to treat, or if the maximum recommended treatment duration is reached.


Q: Are there any common over-the-counter pain relievers that interact with Benzel?

Official regulatory documents list several classes of drugs that interact, including CNS Depressants and Anticholinergic Agents. Patient information notes that checking the labels of over-the-counter medications for ingredients that fall into these interacting classes or for other antihistamines is important.


Q: What is the purpose of the different strengths Benzel comes in?

Different dosage strengths of the medicine are manufactured to allow for administration across the approved patient populations. This ensures that the appropriate dose, whether reduced for children or older adults, or standard for other adults, can be administered.


Q: Why is it important to complete the full course of Benzel?

Benzel is approved for temporary, symptomatic relief. Following the full recommended duration aligns with the recommended period of use established for the symptomatic relief of acute symptoms.


Q: What research is currently ongoing about Benzel or similar compounds?

Official research overviews focus on the existing evidence base supporting the current uses of the drug. Information about specific, ongoing studies into new uses or compounds related to Chlorphenamine maleate is not typically included in the official prescribing information.

How should Benzel be stored and disposed of?

Official Storage Conditions

Benzel (Chlorphenamine maleate) must be stored strictly according to the conditions defined in official regulatory documents. Storage must be maintained at Controlled Room Temperature, typically between 20 C and 25 C (68 F and 77 F), and must not exceed 30 C. The medicine requires protection from light and moisture and must be kept in its original container, which should be tightly closed.

Child Safety and Disposal

It is an official regulatory requirement that Benzel be stored out of the sight and reach of children to prevent accidental ingestion. Unused or expired medication must be disposed of in accordance with local regulations.

Medicines should not be thrown away using household wastewater or trash, as required by the Summary of Product Characteristics, unless specifically advised by a local take-back program or pharmacist. The product must not be used beyond the expiry date stated on the package.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Benzel found in:

A-Z Index: